Skip to main content
. 2014 Jul 21;11:124. doi: 10.1186/1742-2094-11-124

Table 2.

Clinical features of mice receiving donor cells from MOG 35-55 -immunized, vehicle-treated or mepazine-treated mice

Donor cells Incidence Day of disease onset Mean maximal clinical score
Vehicle
100% (5/5)
21.0 ± 1.5
4.4 ± 0.3
Mepazine 60% (3/5) 17.7 ± 1.3 2.5 ± 0.7